Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice

Sporadic, yet frequent human infections with avian H5N1 influenza A viruses continue to pose a potential pandemic threat. Poor immunogenicity of unadjuvanted H5N1 vaccines warrants developing novel adjuvants and formulations as well as alternate delivery systems to improve their immunogenicity and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Weiping, Kim, Jin Hyang, Reber, Adrian J., Hoelscher, Mary, Belser, Jessica A., Lu, Xiuhua, Katz, Jacqueline M., Gangappa, Shivaprakash, Plante, Martin, Burt, David S., Sambhara, Suryaprakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115484/
https://www.ncbi.nlm.nih.gov/pubmed/28499553
http://dx.doi.org/10.1016/j.vaccine.2017.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115484/
https://www.ncbi.nlm.nih.gov/pubmed/28499553
http://dx.doi.org/10.1016/j.vaccine.2017.05.004

Ejemplares similares